Functional inhibitory human leucocyte antigen class I receptors on natural killer (NK) cells in patients with chronic NK lymphocytosis
暂无分享,去创建一个
[1] F. Jotereau,et al. Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy1 , 2002, The Journal of Immunology.
[2] L. Zitvogel,et al. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. , 2002, European cytokine network.
[3] D. Margulies,et al. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. , 2002, Annual review of immunology.
[4] M. Caligiuri,et al. The biology of human natural killer-cell subsets. , 2001, Trends in immunology.
[5] K. Oshimi,et al. Differentiation stage of natural killer cell‐lineage lymphoproliferative disorders based on phenotypic analysis , 2001, British journal of haematology.
[6] Angel Porgador,et al. Recognition of viral hemagglutinins by NKp44 but not by NKp30 , 2001, European journal of immunology.
[7] J. Miller,et al. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. , 2001, Blood.
[8] L. Moretta,et al. New nomenclature for MHC receptors , 2001, Nature Immunology.
[9] L. Lanier,et al. Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors. , 2001, International immunology.
[10] C. Sutherland,et al. The UL16‐binding proteins, a novel family of MHC class I‐related ligands for NKG2D, activate natural killer cell functions , 2001, Immunological reviews.
[11] R. Biassoni,et al. Human natural killer cell receptors and co‐receptors , 2001, Immunological reviews.
[12] William H. Carr,et al. Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism1 , 2001, The Journal of Immunology.
[13] Angel Porgador,et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells , 2001, Nature.
[14] A. Tefferi,et al. Natural Killer Cells and the Syndrome of Chronic Natural Killer Cell Lymphocytosis , 2001, Leukemia & lymphoma.
[15] R. Biassoni,et al. Identification of NKp80, a novel triggering molecule expressed by human NK cells , 2001, European journal of immunology.
[16] T. Loughran,et al. T cell and NK cell lymphoproliferative disorders. , 2001, Hematology. American Society of Hematology. Education Program.
[17] L. Quintanilla‐Martinez,et al. Aggressive NK cell lymphomas: insights into the spectrum of NK cell derived malignancies , 2000, Histopathology.
[18] M. Colonna,et al. Natural killer‐type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T‐cell type , 2000, British journal of haematology.
[19] Y. Tokura,et al. Disordered expression of inhibitory receptors on the NK1‐type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites , 2000, Clinical and Experimental Immunology.
[20] C. Witt,et al. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. , 1999, Transplantation.
[21] T. Loughran,et al. Current concepts: large granular lymphocyte leukemia. , 1999, Blood reviews.
[22] H. Warren. Using carboxyfluorescein diacetate succinimidyl ester to monitor human NK cell division: Analysis of the effect of activating and inhibitory class I MHC receptors , 1999, Immunology and cell biology.
[23] P. Bjorkman,et al. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. , 1999, Immunity.
[24] R. Phyliky,et al. A long‐term study of patients with chronic natural killer cell lymphocytosis , 1999, British journal of haematology.
[25] A Steinle,et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.
[26] K. Akashi,et al. Interferon-gamma prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. , 1999, Blood.
[27] J. Coligan,et al. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. , 1999, Journal of immunology.
[28] R. Bellomo,et al. Transforming growth factor‐β‐induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes , 1999, European journal of immunology.
[29] M. Colonna,et al. A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. , 1999, Current topics in microbiology and immunology.
[30] D. Cosman,et al. Interactions of LIRs, a family of immunoreceptors expressed in myeloid and lymphoid cells, with viral and cellular MHC class I antigens. , 1999, Current topics in microbiology and immunology.
[31] M. Caligiuri,et al. Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15 , 1998 .
[32] J. Coligan,et al. Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis , 1998, The Journal of experimental medicine.
[33] J. Bell,et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.
[34] R. Bellomo,et al. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Caligiuri,et al. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15. , 1998, Blood.
[36] P Parham,et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.
[37] P Parham,et al. Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.
[38] R. Nash,et al. Spontaneous resolution of p58/EB6 antigen restricted NK‐type lymphoproliferative disease of granular lymphocytes: role of Epstein Barr virus infection , 1997, British journal of haematology.
[39] S. Foung,et al. Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes. , 1997, Blood.
[40] K. Oshimi,et al. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. , 1997, Blood.
[41] F Rodeghiero,et al. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. , 1997, Blood.
[42] H. Kanegane,et al. Chronic persistent Epstein‐Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion , 1996, British journal of haematology.
[43] Eric O Long,et al. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. , 1996, Immunology today.
[44] P. Pontisso,et al. Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes. , 1995, Leukemia.
[45] L. Lanier,et al. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. , 1995, Journal of immunology.
[46] H. Warren,et al. Differential expression of CD45R0 on natural killer (NK) cells in patients with an NK lymphocytosis , 1994, Immunology and cell biology.
[47] E. Ciccone,et al. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. , 1993, Blood.
[48] H. Warren,et al. Human natural killer (NK) cells: Requirements for cell proliferation and expansion of phenotypically novel subpopulations , 1993, Immunology and cell biology.